Status:
TERMINATED
Treating Refractory Schizophrenia With rTMS
Lead Sponsor:
Seton Healthcare Family
Collaborating Sponsors:
Abbott Medical Devices
University of Texas at Austin
Conditions:
Schizophrenia
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Symptomatic treatment of the negative symptoms in schizophrenia (such as social withdrawal, affective flattening, poor motivation, and apathy) with medications and psychotherapy are almost non-existen...
Detailed Description
Background and Significance There is increasing evidence from neuropsychological and imaging studies that cerebellar function is relevant not only to motor coordination, but equally to cognition and ...
Eligibility Criteria
Inclusion
- Patients enrolling to the study:
- must be stable on their medications at the start of their enrollment in the study and throughout the duration of the study;
- must have no history of substance use of substance-dependence issues over at least the past six months;
- must be able to and have the capacity to provide consent;
- and if older patient, he/she must be able to participate without a safeguard to be present.
Exclusion
- Patients excluded from the study are:
- Patients with typical clinical considerations that exclude them from treatment with TMS (i.e., patients who have had head injuries, patients with metal implants, patients with a history of seizures, patients with elevated risk of seizures, patients who are taking medications that may interfere with TMS or potentiate the related side effects, etc.).
- Patients who have had changes in their medications (i.e., patients must be stable on their medications throughout their participation in the study).
- Patients with history of substance abuse or substance-dependence anytime over the past six months.
- Patients who are unable (i.e., do not have the capacity) to consent.
Key Trial Info
Start Date :
January 24 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 11 2018
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT02242578
Start Date
January 24 2011
End Date
June 11 2018
Last Update
April 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seton Brain and Spine Institute "Brain Stimulation Laboratory"
Austin, Texas, United States, 78701